What is Driving the Growth of the Artificial Intelligence in Oncology Market?

The global artificial intelligence in oncology market was valued at USD 2.51 billion in 2024 and is projected to reach USD 31.05 billion by 2034, growing at a CAGR of 28.60% from 2025 to 2034. This impressive growth is primarily driven by the rising demand for early and accurate cancer detection, AI integration in drug discovery, and personalized cancer treatment planning.

AI technologies are revolutionizing the oncology sector by enabling faster image analysis, improved diagnostic accuracy, and predictive modeling for treatment outcomes. The continuous evolution of machine learning, deep learning, and natural language processing (NLP) is making AI a critical part of precision oncology and patient management systems.

Market Overview: The AI Revolution in Oncology

Artificial intelligence (AI) in oncology refers to the use of algorithms and data-driven systems to support cancer detection, diagnosis, treatment planning, and drug discovery. By analyzing large datasets from medical imaging, pathology reports, and genomics, AI helps identify hidden patterns that assist clinicians in early diagnosis and treatment decisions.

The growing adoption of AI-based imaging systems and predictive analytics has enhanced diagnostic precision and reduced manual workload for oncologists. Additionally, pharmaceutical companies are increasingly leveraging AI for drug repurposing and clinical trial optimization, accelerating the development of oncology therapeutics.

Key market growth factors include:

  • Rising cancer prevalence globally.

  • Integration of AI in diagnostic imaging and molecular analysis.

  • Growing investment in healthcare AI research and infrastructure.

  • Demand for personalized cancer treatment approaches.

  • Collaboration between AI developers and healthcare providers.

Market Size and Share Insights

  • 2024 Market Value: USD 2.51 Billion

  • 2034 Market Forecast: USD 31.05 Billion

  • CAGR (2025–2034): 28.60%

North America currently dominates the global market, attributed to the presence of AI innovators like Tempus AI, iCAD Inc., and Paige AI, robust healthcare infrastructure, and strong government funding in cancer research. Meanwhile, Asia Pacific is expected to witness the fastest growth due to increasing healthcare digitization and AI adoption in cancer screening programs.

Market Breakup by Offerings

  • Software:

    • Dominates the market, supporting AI-based diagnostic imaging, data analytics, and workflow automation.

  • Hardware:

    • Includes advanced computing systems and imaging devices equipped with AI integration.

  • Services:

    • Covers installation, integration, and AI model training for oncology applications.

Market Breakup by Technology

  • Machine Learning (ML): Enables predictive analytics and diagnostic pattern recognition.

  • Natural Language Processing (NLP): Helps analyze clinical notes and pathology reports for better insight.

  • Context-Aware Processing and Computing: Improves AI interpretation by understanding data relevance.

  • Computer Vision: Enhances accuracy in imaging analysis and tumor segmentation.

  • Others: Include hybrid AI systems integrating genomics and radiomics data.

Market Breakup by Application

  • Drug Discovery and Development:

    • AI identifies novel drug targets and predicts compound efficacy, reducing R&D timelines.

  • Diagnosis and Early Detection:

    • AI-powered tools assist in analyzing mammograms, CT scans, and MRI results for early cancer identification.

  • Treatment Planning and Personalization:

    • AI supports precision oncology, tailoring treatment to individual genetic profiles.

  • Patient Engagement and Remote Monitoring:

    • Wearable AI systems help monitor patients undergoing cancer therapy.

  • Post-Treatment Surveillance and Care:

    • Predicts recurrence risk and assists in long-term patient management.

  • Data Management and Analytics:

    • Integrates multiple healthcare datasets for actionable cancer insights.

Market Breakup by Cancer Type

  • Breast Cancer: Largest market share due to rising AI-based mammography tools.

  • Lung Cancer: Increasing adoption of AI for image segmentation and nodules detection.

  • Colorectal Cancer: AI-driven colonoscopy image analysis improving detection rates.

  • Brain Cancer: AI assists in MRI analysis for tumor mapping and treatment response tracking.

  • Leukemia and Lymphoma: Predictive AI models enable treatment outcome forecasting.

  • Others: Include prostate, pancreatic, and ovarian cancers with expanding AI integration.

Market Breakup by End User

  • Hospitals: Major adopters of AI in diagnostics and treatment workflows.

  • Oncology Clinics: Utilize AI for decision support and therapy optimization.

  • Academic and Research Institutes: Drive innovation through AI-enabled cancer research.

  • Medical Device Companies: Integrate AI into imaging devices and diagnostic systems.

  • Others: Include telehealth platforms and AI-driven patient monitoring startups.

Market Breakup by Region

North America

Leads the market due to robust AI adoption, advanced cancer care facilities, and ongoing government support for AI research.

Europe

Shows steady growth supported by digital healthcare initiatives and AI investments in oncology diagnostics.

Asia Pacific

Expected to grow at the highest CAGR, driven by AI-based cancer screening programs in China, Japan, and India.

Latin America

Gradual adoption supported by healthcare modernization and increased awareness.

Middle East and Africa

Emerging AI deployments in oncology diagnostics, especially in the UAE and South Africa.

Key Market Trends

  • Rising adoption of AI-powered diagnostic imaging platforms.

  • Integration of multi-omics data (genomic, proteomic, and imaging).

  • Growth in cloud-based AI solutions for oncology data management.

  • Collaborations between tech companies and healthcare organizations.

  • Shift toward explainable AI for improved clinician trust.

Market Challenges

Despite strong growth potential, the market faces certain challenges:

  • Data privacy concerns in handling patient medical records.

  • Limited AI interpretability in complex oncology cases.

  • High implementation costs and lack of skilled professionals.

  • Regulatory barriers delaying product approvals in some regions.

Leading Companies in the Artificial Intelligence in Oncology Market

  • Aidoc

  • iCAD Inc.

  • Microsoft Corporation

  • Cancer Center.ai

  • Mursla Bio

  • SkinVision

  • Kheiron Medical Technologies Limited

  • Therapixel

  • Tempus AI, Inc.

  • Paige AI Inc.

These companies focus on developing AI-driven oncology software for early detection, treatment optimization, and patient data analysis to improve clinical decision-making.

Future Outlook

The future of artificial intelligence in oncology is expected to revolve around integrated cancer care systems, where AI supports every stage—from detection to recovery. Enhanced computing power, improved regulatory frameworks, and global collaborations will further accelerate adoption. By 2034, AI will likely be a core component of personalized oncology treatment models.

Uncover More Reports

Genomics Market

Legal Marijuana Market

Telemedicine Market

Skincare Devices Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com